Anna Pastore1, Annalisa Noce2, Gianna Di Giovamberardino3, Alessandro De Stefano4, Cinzia Callà5, Rossella Zenobi4, Mariarita Dessì4, Nicola Di Daniele2. 1. Metabolomic and Proteomic Unit, Children's Hospital "Bambino Gesù", IRCCS, P.zza S. Onofrio, 4, 00165, Rome, Italy. anna.pastore@opbg.net. 2. Department of Internal Medicine, Nephrology and Hypertension Unit, "Tor Vergata" University Hospital, Rome, Italy. 3. Metabolomic and Proteomic Unit, Children's Hospital "Bambino Gesù", IRCCS, P.zza S. Onofrio, 4, 00165, Rome, Italy. 4. Department of Laboratory Medicine, "Tor Vergata" University Hospital, Rome, Italy. 5. Department of Laboratory Medicine, "Policlinico Gemelli" University Hospital, Rome, Italy.
Abstract
BACKGROUND: Hyperhomocysteinemia (hHcy) is a risk factor in the progression of chronic kidney disease (CKD). In type 2 diabetes (T2D), hHcy is strongly associated with increased risk of cardiovascular disease. Vitamin B12 and folic acid supplementation have been reported to lower homocysteine (tHcy) levels, but no data on plasma tHcy, cysteine (Cys), folate and vitamin B12 levels in T2D-CKD patients are reported. PROCEDURES: tHcy and Cys levels were analyzed in 178 T2D-CKD patients by high performance liquid chromatography (HPLC) with fluorescence detection. In addition, we determined folate and vitamin B12 levels using a chemiluminescence method. RESULTS: tHcy and Cys levels were increased in T2D patients, and this rise positively correlated with the CKD stage (P < 0.001). Folate levels were comparable to controls at various CKD stages, whereas vitamin B12 levels were lower, except at stage IV. We did not find any correlation between B-vitamins and levels of tHcy and Cys, regardless of the CKD stage. CONCLUSIONS: This is the first study reporting tHcy, Cys and B-vitamins status in T2D-CKD patients. Although limited to our cohort of 178 patients, our findings could be helpful in clarifying the conflicting literature regarding B-vitamins supplementation. Further studies are necessary before any Hcy-lowering therapy can be safely established in T2D-CKD subjects.
BACKGROUND:Hyperhomocysteinemia (hHcy) is a risk factor in the progression of chronic kidney disease (CKD). In type 2 diabetes (T2D), hHcy is strongly associated with increased risk of cardiovascular disease. Vitamin B12 and folic acid supplementation have been reported to lower homocysteine (tHcy) levels, but no data on plasma tHcy, cysteine (Cys), folate and vitamin B12 levels in T2D-CKD patients are reported. PROCEDURES: tHcy and Cys levels were analyzed in 178 T2D-CKD patients by high performance liquid chromatography (HPLC) with fluorescence detection. In addition, we determined folate and vitamin B12 levels using a chemiluminescence method. RESULTS:tHcy and Cys levels were increased in T2D patients, and this rise positively correlated with the CKD stage (P < 0.001). Folate levels were comparable to controls at various CKD stages, whereas vitamin B12 levels were lower, except at stage IV. We did not find any correlation between B-vitamins and levels of tHcy and Cys, regardless of the CKD stage. CONCLUSIONS: This is the first study reporting tHcy, Cys and B-vitamins status in T2D-CKD patients. Although limited to our cohort of 178 patients, our findings could be helpful in clarifying the conflicting literature regarding B-vitamins supplementation. Further studies are necessary before any Hcy-lowering therapy can be safely established in T2D-CKD subjects.
Authors: Nur Aksoy; Mehmet Aksoy; Mahmut Cakmak; Hasan Serdar Gergerlioglu; Vedat Davutoglu; Serdar Soydinc; Iclal Meram Journal: Clin Chem Lab Med Date: 2006 Impact factor: 3.694
Authors: Claudia U Chae; Christine M Albert; Robert J Glynn; Jack M Guralnik; Gary C Curhan Journal: Am J Cardiol Date: 2003-09-15 Impact factor: 2.778
Authors: Rajagopal V Sekhar; Siripoom V McKay; Sanjeet G Patel; Anuradha P Guthikonda; Vasumathi T Reddy; Ashok Balasubramanyam; Farook Jahoor Journal: Diabetes Care Date: 2010-10-07 Impact factor: 19.112
Authors: Anna Pastore; Anna Alisi; Gianna di Giovamberardino; Annalisa Crudele; Sara Ceccarelli; Nadia Panera; Carlo Dionisi-Vici; Valerio Nobili Journal: Int J Mol Sci Date: 2014-11-17 Impact factor: 5.923
Authors: Samuel Bernardo-Bermejo; Elena Sánchez-López; María Castro-Puyana; Selma Benito-Martínez; Francisco Javier Lucio-Cazaña; María Luisa Marina Journal: Molecules Date: 2020-01-24 Impact factor: 4.411